Stage IIIA Breast Cancer Terminated Phase 3 Trials for Cefotaxime (DB00493)

IndicationStatusPhase
DBCOND0028774 (Stage IIIA Breast Cancer)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00016276Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerTreatment